Management of hyperpigmentation: Current treatments and emerging therapies
Pigment Cell & Melanoma Research · 2021-11 · 34 (6) · 1000-1014
DOI: 10.1111/pcmr.12986 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 03.06.2021. Verfasst von Avni Nautiyal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKMs NMIMS, Mumbai, India. Die Arbeit wurde bisher 184-mal zitiert (Crossref) und nennt 110 Literaturangaben.
Abstract (Originalsprache)
Hyperpigmentation of the skin refers to a dermatological condition which alters the color of the skin, making it discolored or darkened. The treatments for hyperpigmentation disorders often take very long to show results and have poor patient compliance. The first‐line treatment for hyperpigmentation involves topical formulations of conventional agents such as hydroquinone, kojic acid, and glycolic acid followed by oral formulations of therapeutic agents such as tranexamic acid, melatonin, and cysteamine hydrochloride. The second‐line approaches include chemical peels and laser therapy given under the observation of expert professionals. However, these therapies pose certain limitations and adverse effects such as erythema, skin peeling, and drying and require long treatment duration to show visible effects. These shortcomings of the conventional treatments provided scope for further research on newer alternatives for managing hyperpigmentation. Some of these therapies include novel formulations such as solid lipid nanocarriers, liposomes, phytochemicals, platelet‐rich plasma, microneedling. This review focuses on elaborating on several hyperpigmentation disorders and their mechanisms, the current, novel and emerging treatment options for management of hyperpigmentation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKMs NMIMS, Mumbai, India.
ORCID-Profile: Sarika Wairkar
Zitieren
APA
Nautiyal, A., & Wairkar, S. (2021). Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell & Melanoma Research, 34(6), 1000-1014. https://doi.org/10.1111/pcmr.12986
Vancouver
Nautiyal A, Wairkar S. Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell & Melanoma Research. 2021;34(6):1000-1014. doi:10.1111/pcmr.12986
BibTeX
@article{Nautiyal2021,
author = {Nautiyal, Avni and Wairkar, Sarika},
title = {Management of hyperpigmentation: Current treatments and emerging therapies},
journal = {Pigment Cell & Melanoma Research},
year = {2021},
volume = {34},
number = {6},
pages = {1000--1014},
doi = {10.1111/pcmr.12986}
}
EUVIMED